chartexchange

MDNAF
MEDICENNA THERA CORP
stockOTC

EODNov 18, 2026
0.125USD-21.875%(-0.035)541,334
Loading…
Loading…
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Previous Close
$0.16
Beta
0.64
52-Week High
$1.30 2025-12-10
52-Week Low
$0.11 2026-11-18
SMA 50
$0.29
SMA 200
$0.38
Avg. Vol 10D
164,526
Avg. Vol 30D
74,391
Avg. Vol 90D
57,754
Relative Vol
7.28
62.41M
500
MDNAF Profile

medicenna is a clinical stage immunotherapy company developing novel highly selective versions of il-2, il-4 and il-13 superkines and first in class empowered cytokines (ecs). our mission is to become the leader in the development and commercialization of targeted ecs and superkines for the treatment of a broad range of cancers and immune-mediated diseases. we seek to achieve these successful treatments by drawing on our expertise, and that of world-class collaborators, to develop a unique set of superkines. these superkines can be developed either on their own as short or long-acting therapeutics or fused with pro-apoptotic proteins in order to precisely deliver potent cell-killing agents to the cancer cells as well as the immunosuppressive tumor micro-environment and the cancer stem cells without harming healthy cells. superkines can also be fused with other types of proteins such as antibodies to generate novel "immunocytokines" or combined with other treatment modalities such as ca

MDNAF Performance
PeriodPriceDateChangeBeta
1W0.282026-11-12-55.38%-2.353
1M0.282026-10-19-55.21%1.892
3M0.302026-08-19-58.33%1.543
6M0.342026-05-19-63.64%0.795
1Y1.032025-11-19-87.86%0.641
2Y1.162024-11-19-89.22%—
5Y4.672020-08-21-97.32%0.068
MDNAF Stock Summary

MEDICENNA THERA CORP (OTC:MDNAF) stock price today is $0.13, and today's volume is 541,334. MDNAF is down 21.875% today. The 30 day average volume is 74,391. MDNAF market cap is $9.59M with 76.71M shares outstanding.